Medical Center Akad. Iv. Penchev EOOD
- Address
- Ulitsa Zdrave 2, 1431 Sofia, Bulgaria
Medical Center Akad. Iv. Penchev EOOD
Medical Center Akad. Iv. Penchev EOOD is a specialized clinical research facility with demonstrated expertise in complex immunological conditions and metabolic disorders. The center conducts advanced Phase 2 clinical trials, focusing on novel therapeutic interventions for chronic conditions that significantly impact patient quality of life.
- Chronic Inducible Urticaria and dermatological immunology, including Cold Urticaria and Symptomatic Dermographism
- Chronic Kidney Disease management with innovative dosing strategies
- Metabolic conditions including Type 2 Diabetes and Obesity in renal disease populations
The facility specializes in evaluating dose-response relationships and conducting randomized, double-blind, placebo-controlled studies to assess both efficacy and safety of investigational therapeutics. Their research in urticaria focuses on patients with H1-antihistamine refractory disease, utilizing provocation testing methodologies, while their nephrology program evaluates subcutaneous therapies aimed at reducing urinary albumin-to-creatinine ratio (UACR) as a key marker of kidney damage progression.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 13 of 14 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Arrowhead Pharmaceuticals Inc.2active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novo Nordisk A/S5trials
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center Akad. Iv. Penchev EOOD
lock Showing 1 of 21 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized Study of IMVT-1402 Versus Placebo in Adult Patients with Graves' Disease | Immunovant Sciences GmbH | Phase II | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 14 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues | 4 | Unknown | 2024-11-04 | 2025-12-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.